Ciprofloxacin-resistant Aeromonas hydrophila infection following leech therapy: a case report and review of the literature

J Plast Reconstr Aesthet Surg. 2013 Jan;66(1):e20-2. doi: 10.1016/j.bjps.2012.10.002. Epub 2012 Oct 18.

Abstract

Compromised flap perfusion can lead to the use of leech therapy to aid in flap salvage. Aeromonas hydrophila, a symbiont of the leech, is a well-known bacterial pathogen that has the potential to cause infection in patients receiving leech therapy. Ciprofloxacin is commonly regarded as the antibiotic of choice for prophylaxis against this pathogen. We present patient who underwent leech therapy during salvage attempts for a venous congested flap. A resultant infection developed despite being on appropriate antibiotics. Culture sensitivities indicated that A. hydrophila was resistant to ciprofloxacin.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aeromonas hydrophila
  • Anti-Bacterial Agents / therapeutic use*
  • Antibiotic Prophylaxis*
  • Aztreonam / therapeutic use
  • Ciprofloxacin / therapeutic use*
  • Drug Resistance, Bacterial*
  • Female
  • Gram-Negative Bacterial Infections / drug therapy
  • Gram-Negative Bacterial Infections / microbiology
  • Gram-Negative Bacterial Infections / prevention & control*
  • Humans
  • Leeching / adverse effects*
  • Middle Aged

Substances

  • Anti-Bacterial Agents
  • Ciprofloxacin
  • Aztreonam